Evaluation of Scintillating Nanoparticles for Radiotherapy and PDT

闪烁纳米颗粒放射治疗和 PDT 的评价

• 批准号: 7593845
• 负责人: Paul Smith
• 金额: $ 0.98万
• 依托单位: NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7593845
• 关键词: Address; Area; Attenuated; Brachytherapy; Cells; Chemicals; Depth; Dose; Equipment; Evaluation; Fiber Optics; Lanthanoid Series Elements; Light; Literature; Measurable; Measurement; Measures; Methods; Modeling; Optics; Paper; Penetration; Photochemotherapy; Photosensitizing Agents; Phototoxicity; Process; Publications; Publishing; Radiation; Radiation therapy; Radiation-Sensitizing Agents; Research; Roentgen Rays; Sampling; System; Therapeutic; Tissues; Tube; Tumor Tissue; Visible Radiation; Writing; absorption; base; irradiation; killings; lens; light emission; nanoparticle; photomultiplier; skin disorder; uptake

Photodynamic therapy (PDT), in which cells are targeted with a chemical photosensitizer and then killed when irradiated with light, has been long been an area of active research, and is also used clinically, primarily to treat skin disease. However, the use of PDT for deep tumor tissues has been hampered by poor light penetration. Although near-infrared light can penetrate several centimeters into tissue, the currently available photosensitizers are much more efficiently excited by visible light, which is rapidly attenuated. To address this problem, a recently published paper proposed using scintillating nanoparticles conjugated to photosensitizers for x-ray stimulated photodynamic therapy. In this system, the x-rays would stimulate visible light emission from the nanoparticles, exciting the attached photosensitizers. The obvious advantage of this system over conventional methods is the deep tissue penetration of x-rays. In addition, it is possible that a nanoparticle photosensitizing agent could be more selectively targeted to tumor tissue than current agents. In order for this proposed method to be feasible, the phototoxicity of the nanoparticle-photosensitizer conjugates must be measurable at therapeutic radiation doses or below. We assembled experimental apparatus consisting of a cuvette holder, collimating lenses, a fiber optic cable, an optical bandpass filter and a photomultiplier tube, and used this equipment to measure the light yield of nanoparticle samples under irradiation. We also drew on results from the literature for PDT dose, lanthanide light yields, lanthanide absorption and nanoparticle uptake into targeted tissue to evaluate the feasibility of this proposal. The results of our calculations suggest that for reasonably high but attainable light yields, these nanoparticle conjugates could potentially be useful as radiosensitizers, especially in brachytherapy applications for which the X-ray energies are sub-MeV. We are in the process of writing up our results for publication.

光动力疗法（PDT）是一种化学光敏剂靶向细胞，然后在光照射下杀死细胞的疗法，长期以来一直是一个活跃的研究领域，也用于临床，主要用于治疗皮肤病。然而，由于光线穿透性差，PDT在深部肿瘤组织中的应用一直受到阻碍。虽然近红外光可以穿透组织几厘米，但目前可用的光敏剂被可见光激发的效率要高得多，而可见光会迅速衰减。